Skip to main content

Table 1 Clinical data and PET/CT findings in 31 patients with NSCLC

From: A pilot study of 4′-[methyl-11C]-thiothymidine PET/CT for detection of regional lymph node metastasis in non-small cell lung cancer

Patient no. Age Sex Pathology Tumor diameter (mm) TNM classification Lymph node staging SUVmax
         Primary lung lesion Mediastinal positive uptake Ascending aorta
       4DST FDG 4DST FDG 4DST FDG 4DST FDG
1 56 M Adeno 31 pT2aN0M0 N0 N0 4.7 10.9 - - 0.6 1.6
2 79 F Adeno 14, 18 pT1aN0M0 N0 N0 1.8 to 2.1 1.3 to 2.8 - - 1.1 2.2
3 55 F Adeno 18 pT1aN0M0 N0 N0 4.1 7.7 - - 1.0 1.7
4 60 M Adeno 15 pT1aN2M0 N2 N0 1.5 1.4 1.7 - 0.7 1.7
5 69 M Adeno 12 pT3N1M0 N2 N2 2.7 13.7 1.9 to 3.1 2.0 to 2.7 0.6 1.6
6 62 M Adeno 32 pT2aN2M0 N2 N2 3.5 7.1 1.6 to 3.5 2.9 to 3.6 0.9 1.9
7 77 F Adeno 20 pT1aN0M0 N0 N0 2.7 4.5 - - 0.8 2.2
8 73 F Adeno 15 pT2aN0M0 N3 N3 2.7 5.2 2.7 to 4.4 3.6 to 5.8 1.0 2.1
9 58 M SCC 30 pT2aN1M0 N2 N0 3.0 5.6 2.1 to 2.5 - 0.8 1.7
10 55 M Large cell 62 pT2bN1M0 N2 N2 3.2 7.6 1.9 to 2.0 1.7 1.0 1.8
11 72 M Adeno 55 pT2bN0M0 N1 N0 4.5 10.1 3.0 - 0.9 2.3
12 74 M SCC 30 pT2aN0M0 N1 N1 3.9 17.3 4.2 3.1 1.0 2.1
13 78 M Adeno 38 pT2aN0M0 N0 N1 4.0 6.3 - 2.3 0.9 2.0
14 73 M Adeno 20 pT1aN0M0 N2 N1 2.1 3.6 2.9 to 3.0 2.5 to 3.3 0.6 2.3
15 79 M Adeno 19 pT1aN0M0 N2 N0 3.0 4.2 2.4 to 2.6 - 0.7 2.1
16 58 F Adeno 18 pT1aN2M0 N2 N0 1.5 3.5 3.9 to 4.2 - 0.6 2.2
17 54 M SCC 32 pT2aN0M0 N2 N0 1.6 0.8 2.2 - 0.7 1.6
18 84 M Adeno 19 pT1aN0M0 N0 N0 1.9 1.2 - - 0.5 2.1
19 76 M Adeno 25 pT2aN0M0 N2 N0 6.5 13.5 3.0 to 5.3 - 0.6 1.8
20 75 M Adeno 42 pT2aN2M0 N2 N0 5.2 3.6 1.7 - 0.7 2.0
21 70 M SCC 45 pT3N1M0 N2 N0 5.6 15.7 2.8 to 2.9 - 0.4 1.7
22 73 M Large cell 19 pT1aN0M0 N2 N0 2.8 4.2 1.7 to 2.4 - 0.6 1.8
23 76 M Large cell 17 pT1aN2M0 N2 N2 1.7 2.8 2.1 to 3.1 4.1 to 4.4 0.4 1.5
24 88 M SCC 70 pT3N0M0 N2 N2 5.1 18.8 4.7 to 5.6 2.7 to 3.6 0.4 1.9
25 36 F Adeno 21 pT1bN0M0 N1 N1 4.4 3.3 2.9 2.7 0.7 2.0
26 76 F SCC 60 pT2bN0M0 N2 N2 4.8 18.1 2.3 to 2.4 2.2 to 2.3 0.5 1.7
27 43 F Adeno 28 pT2aN0M0 N1 N0 2.4 9.3 1.6 - 0.9 1.9
28 70 M Adeno 20 T1bN2M1a N2 N2 3.0 3.0 2.0 to 3.3 3.0 0.4 1.9
29 69 F Adeno 22 T1aN0M1a N3 N0 2.5 2.8 1.6, 1.6 - 0.6 1.7
30 70 M Adeno 37 T2aN0M1a N3 N0 4.7 12.2 2.6 to 4.9 - 0.7 2.3
31 61 F Adeno 32 T2aN2M1a N2 N2 3.3 8.9 1.7 to 4.1 3.1 0.5 1.6
  1. NSCLC, non-small cell lung cancer; SUVmax, maximum standardized uptake value; M, male; F, female; Adeno, adenocarcinoma; SCC, squamous cell carcinoma; Large cell, large cell carcinoma.